Zai Lab
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zai Lab and other ETFs, options, and stocks.About ZLAB
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra.
CEOYing Du
CEOYing Du
Employees1,869
Employees1,869
HeadquartersShanghai, Shanghai
HeadquartersShanghai, Shanghai
Founded2014
Founded2014
Employees1,869
Employees1,869
ZLAB Key Statistics
Market cap2.13B
Market cap2.13B
Price-Earnings ratio-9.63
Price-Earnings ratio-9.63
Dividend yield—
Dividend yield—
Average volume840.88K
Average volume840.88K
High today$19.79
High today$19.79
Low today$19.62
Low today$19.62
Open price$18.69
Open price$18.69
Volume6.74K
Volume6.74K
52 Week high$44.34
52 Week high$44.34
52 Week low$15.96
52 Week low$15.96
ZLAB News
TipRanks 21h
Zai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should WatchZai Lab Ltd (ZLAB) announced an update on their ongoing clinical study. The phase 1a/b study “An Open-label, Phase 1a/b, Multicenter Study of ZL-6201 to Evalua...
TipRanks 2d
Zai Lab Sets February 26 Board Meeting to Approve and Release 2025 Annual ResultsZai Lab Ltd ( (HK:9688) ) has provided an announcement. Zai Lab Limited has scheduled a board meeting for February 26, 2026 to consider and approve its audited...
Analyst ratings
85%
of 13 ratingsBuy
84.6%
Hold
15.4%
Sell
0%